147 related articles for article (PubMed ID: 1718643)
1. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.
Fearon DT
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):43-6. PubMed ID: 1718643
[TBL] [Abstract][Full Text] [Related]
2. Complement alternative pathway activation and control on membranes of human lymphoid B cell lines.
Caudwell V; Porteu F; Calender A; Pangburn MK; Halbwachs-Mecarelli L
Eur J Immunol; 1990 Dec; 20(12):2643-50. PubMed ID: 1702720
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the immune response by a soluble complement receptor of B lymphocytes.
Hebell T; Ahearn JM; Fearon DT
Science; 1991 Oct; 254(5028):102-5. PubMed ID: 1718035
[TBL] [Abstract][Full Text] [Related]
4. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
Kalli KR; Hsu PH; Bartow TJ; Ahearn JM; Matsumoto AK; Klickstein LB; Fearon DT
J Exp Med; 1991 Dec; 174(6):1451-60. PubMed ID: 1836011
[TBL] [Abstract][Full Text] [Related]
5. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
[TBL] [Abstract][Full Text] [Related]
6. [Complement regulatory proteins].
Miyagawa S
Nihon Rinsho; 2005 Apr; 63 Suppl 4():274-8. PubMed ID: 15861668
[No Abstract] [Full Text] [Related]
7. A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro.
Christiansen D; Milland J; Thorley BR; McKenzie IF; Loveland BE
Eur J Immunol; 1996 Mar; 26(3):578-85. PubMed ID: 8605924
[TBL] [Abstract][Full Text] [Related]
8. [Complement regulatory factors and immunologic recognition mechanism between species].
Seya T; Matsunoto M
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):637-42. PubMed ID: 8963770
[No Abstract] [Full Text] [Related]
9. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.
Matsumoto AK; Kopicky-Burd J; Carter RH; Tuveson DA; Tedder TF; Fearon DT
J Exp Med; 1991 Jan; 173(1):55-64. PubMed ID: 1702139
[TBL] [Abstract][Full Text] [Related]
10. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.
Kinoshita T; Thyphronitis G; Tsokos GC; Finkelman FD; Hong K; Sakai H; Inoue K
Int Immunol; 1990; 2(7):651-9. PubMed ID: 1703784
[TBL] [Abstract][Full Text] [Related]
11. [Self- and non-self recognition mechanism via the complement system].
Okada N
Nihon Rinsho; 2005 Apr; 63 Suppl 4():279-83. PubMed ID: 15861669
[No Abstract] [Full Text] [Related]
12. Complement regulation.
Meri S; Jarva H
Vox Sang; 1998; 74 Suppl 2():291-302. PubMed ID: 9704459
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
[TBL] [Abstract][Full Text] [Related]
14. Human regulator of complement activation (RCA) gene family proteins and their relationship to microbial infection.
Seya T
Microbiol Immunol; 1995; 39(5):295-305. PubMed ID: 7565169
[No Abstract] [Full Text] [Related]
15. Structure and signalling functions of C3 receptors on human B cells.
Frade R
Semin Immunol; 1990 Mar; 2(2):159-64. PubMed ID: 2151800
[TBL] [Abstract][Full Text] [Related]
16. Cell surface proteins reacting with activated complement components.
Becherer JD; Alsenz J; Servis C; Myones BL; Lambris JD
Complement Inflamm; 1989; 6(3):142-65. PubMed ID: 2526003
[TBL] [Abstract][Full Text] [Related]
17. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT
J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506
[TBL] [Abstract][Full Text] [Related]
18. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
Kazatchkine MD; Fearon DT
Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
[TBL] [Abstract][Full Text] [Related]
19. Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.
Carroll MC; Alicot EM; Katzman PJ; Klickstein LB; Smith JA; Fearon DT
J Exp Med; 1988 Apr; 167(4):1271-80. PubMed ID: 2451706
[TBL] [Abstract][Full Text] [Related]
20. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
